Consistent Benefit of Control-IQ+ Automated Insulin Delivery Across a Range of Characteristics of Adults with Type 2 Diabetes
The glycemic benefit of AID was observed across a wide range of participant characteristics. Furthermore, there were no identifiable characteristics that were associated with unsuccessful use of AID or a lack of beneficial glycemic response with AID. Therefore, AID should be a consideration for all adults with insulin-treated type 2 diabetes.
Authors
- John Lum
- A. G. Lynn
- Lauren Kanapka
- Jordan E. Pinsker
- for the 2IQP Study Group
- Lakshmi G. Singh
Institutions
- Tandem Diabetes Care (United States) (US)
- Jaeb Center for Health Research (US)
- Baltimore VA Medical Center (US)
Publication Details
- Journal
- Diabetes Technology & Therapeutics
- Published
- 2026-01-23
- DOI
- https://doi.org/10.1177/15209156261416920
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00